Theorem Clinical Research

Global News

International Progressive MS Alliance awards $28.4M in research grants

Tuesday, September 16, 2014 08:00 AM

The International Progressive MS Alliance has awarded its first round of 22 research grants to investigators in nine countries, with the goal of removing barriers to developing treatments for progressive multiple sclerosis (MS). The alliance is a worldwide collaborative focused on finding solutions to progressive forms of multiple sclerosis that have so far eluded the scientific community.

More... »


Parexel expands Perceptive Partner Program, adds CRF Health and Clinical Ink

Monday, September 15, 2014 12:41 PM

Parexel International, a Massachusetts-based global biopharmaceutical services organization, has announced that clinical technology companies CRF Health, a provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials, and Clinical Ink, a Winston-Salem, N.C.-based eSource solutions company, have joined its Perceptive Partner Program. 

More... »


Trialbee helps AstraZeneca reduce recruitment time of patients to clinical trials

Monday, September 15, 2014 12:38 PM

Swedish e-health company Trialbee has signed a professional service agreement with AstraZeneca for e-recruitment.

More... »

PRA Health Sciences files for initial public offering

Monday, September 15, 2014 12:37 PM

PRA Health Sciences, a Raleigh, N.C.-based CRO, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering (IPO) of shares of its common stock by PRA Health Sciences and an affiliate of Kohlberg Kravis Roberts (the selling stockholder). The number of shares to be offered and the price range has not yet been determined.

More... »

Quintiles launches new customer solution

Monday, September 15, 2014 12:21 PM

Global CRO Quintiles has launched the Quintiles Emerging Biopharma Solution, a new offering designed to meet the unique clinical development needs and goals of emerging biopharmaceutical companies in the global marketplace.

More... »

The Pulse on Study Conduct

Monday, September 15, 2014 07:00 AM

It is important to realize what is really important in both site and staff selection.

More... »

Lilly’s CYRAMZA phase III colorectal cancer trial meets primary endpoint

Friday, September 12, 2014 01:35 PM

Eli Lilly has announced that the RAISE trial, a phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival. The global, randomized, double-blind study compared ramucirumab plus FOLFIRI to placebo plus FOLFIRI as a second-line treatment in patients with mCRC after treatment with bevacizumab, oxaliplatin and a fluoropyrimidine in the first-line setting.

More... »

Gates Foundation commits $50M to support emergency response to Ebola

Friday, September 12, 2014 01:13 PM

The Bill & Melinda Gates Foundation plans to commit $50 million to support the scale up of emergency efforts to contain the Ebola outbreak in West Africa and interrupt transmission of the virus.

More... »

Report: Research indicates mangos may lower blood sugar in obese adults

Friday, September 12, 2014 01:08 PM

Regular consumption of mango by obese adults may lower blood sugar levels and does not negatively impact body weight, according to research published in the journal Nutrition and Metabolic Insights. These are important findings considering that approximately 34% of U.S. adults have been classified as obese and given the health concerns related to obesity, such as type 2 diabetes (T2DM) and metabolic syndrome.

More... »

Evotec, CHDI Foundation extend ongoing Huntington's disease collaboration

Friday, September 12, 2014 01:00 PM

The CHDI Foundation, a U.S. privately-funded nonprofit biomedical research organization, has extended and restated its collaboration with Evotec, a drug discovery solutions company based in Germany, through 2017. The collaboration, which aims to find new treatments for Huntington's disease, an inherited neurodegenerative disorder, means CHDI will fund up to 52 full-time scientists at Evotec over the next three years.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private ἀnancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs